Hitachi and Axcelead DDP Launch Manufacturing Process Development Support Service for Cell Therapy and Gene Therapy
Axcelead Drug Discovery Partners was rated as “Excellent” by Japan Agency for Medical Research and Development (AMED)* in a program for “Drug Discovery Seeds Development”
Axcelead Drug Discovery Partners, Inc. (Axcelead DDP) has …
Phenotypic Drug Discovery Platform
Phenotypic screening is a powerful approach to find novel hit …
High-throughput mass spectrometry for hit identification
Mass spectrometry (MS) has been increasingly used for high throughput …
Integrated HTS platform for innovative drug discovery
High-throughput screening (HTS) is the key methodology to identify hit …
Axcelead has entered into a comprehensive agreement including transfer of key drug discovery platforms with a major Japanese pharmaceutical company
Axcelead Drug Discovery Partners Co., Ltd. (Headquarters: Fujisawa, …
Reliable identification of cardiac cunduction abnormalities in drug discovery using automated patch clamp II: Best practices for Nav1.5 peak current in a high throughput screening enviroment
Journal of Pharmacological and Toxicological Methods